Table 2.
Demographic and clinical baseline characteristics
| Characteristic | Study group – positive aPL (n=20) | Control group – negative aPL (n=35) | P value |
|---|---|---|---|
| Maternal age (years) | 30.2 ± 4.6 | 34.3 ± 7.0 | 0.01 |
| Gravidity | 3 (1-7) | 2 (1-7) | 0.01 |
| Chronic hypertension | 2 (10%) | 7 (20%) | 0.5 |
| Diabetes Mellitus a | 1 (5%) | 6 (17.1%) | 0.2 |
| SLE | 2 (10%) | 1 (2.9%) | 0.6 |
| Genetic thrombophilia b | 3 (15%) | 4 (9.3%) | 1.0 |
| Other c | 2 (10%) | 0 | 0.1 |
Data are presented as median (range) or means (standard deviation) for continuous variables, or as number (percent) for categorical variables.
aPL – Antiphospholipid antibodies; SLE – systemic lupus erythematosus
a
Diabetes Mellitus refers to both pre-gestational and gestational diabetes.
b
Genetic thrombophilia – Heterozygous factor V Leiden or heterozygous factor II (prothrombin mutation 20210A)
c
Other – includes one case of Behҫet’s disease and one case of glomerulonephritis